JP Morgan Chase
CVET

JP Morgan Chase’s Covetrus, Inc. Common Stock CVET Stock Holding History

JP Morgan Chase’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$1.04M – 7376
2022
Q3 		$1.04M Hold
50,000
– – ﹤0.01% 3954
2022
Q2 		$1.04M Buy
+50,000
New +$890K ﹤0.01% 4047

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's CVET Position: Q4 2022 in Review

JP Morgan Chase sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 2,162,578 shares — an estimated $45.2M sold.

JP Morgan Chase first reported a position in CVET in Q1 2019 and held it in 14 quarters. The position peaked at $125M in Q2 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • JP Morgan Chase reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 2,162,578 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $45.2M.
  • JP Morgan Chase first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 14 quarters.
  • JP Morgan Chase's Covetrus, Inc. Common Stock position peaked at $125M in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.